| Statement
of Comprehensive Income |
|
|
|
|
|
| for financial
year ended December 31 2013. |
2013 |
|
2012 |
|
%CHNG |
| |
N'000 |
|
N'000 |
|
|
Revenue |
1,060,308 |
|
1,037,463 |
|
2.20% |
| Cost of Sales |
(616,954) |
|
(546,712) |
|
12.85% |
| Distribution/Admin
and Other Expenses |
(605,042) |
|
(452,396) |
|
33.74% |
| Other Income |
9,963 |
|
56,232 |
|
-82.28% |
| Financial
Charges |
(76,875) |
|
(78,608) |
|
-2.20% |
| Profit/Loss
Before Tax |
(228,600) |
|
15,979 |
|
-1530.63% |
| Taxation |
6,811 |
|
54,169 |
|
-87.43% |
| Profit/Loss
After Tax |
(221,789) |
|
70,148 |
|
-416.17% |
| De-recognization
of Loan Liability |
100,607 |
|
670,797 |
|
-85.00% |
| |
|
|
|
|
|
| |
|
|
|
|
|
| Total
Comprehensive Income |
(121,182) |
|
740,945 |
|
-116.36% |
| |
|
|
|
|
|
| |
|
|
|
|
|
| Profit/Loss
After Tax Attr. To Noncontrolling Int |
- |
|
- |
|
|
| Profit/Loss
After Tax Owners of the Company |
- |
|
- |
|
|
| Total Comp.
Inc.Attr. to Non-Controlling Interest |
- |
|
- |
|
|
| Attributable
to Owners of the Company |
- |
|
- |
|
|
| Basis
Earnings per Share |
(121.2) |
|
744.5 |
|
-116.28% |
| Source -
Pharma Deko / NSE WEBSITE |
|
|
|
|
|
|
|